This paper provides a clear and practical introduction to the regulatory landscape governing THC-containing cannabis in the ...

Synthetic drugs are raising the risk of an epidemic worse than that of fentanyl in the UK and Europe. Marianne Guenot explains what these drugs are and what clinicians need to know Mat Southwell had ...

Colorado, which once served as the model for marijuana regulation, generated billions of dollars in tax revenue while promising to keep consumers safe. Now it’s scrambling to keep harmful hemp off the ...

ProPublica and The Denver Gazette set out to test whether claims of widespread substitution of hemp for marijuana were ...

For many decades, the method to obtain atomic-level descriptions of chemical compounds and materials—be it a drug, a catalyst ...

This week in science: Scientists propose new standard measures for cannabis use; mysterious ancient lifeforms don't ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

A team of scientists has taken a closer look at the origins of cannabis chemistry by reconstructing enzymes from ancient ...

Texas' highest civil court is set to hear and rule on cases dealing with several hot-button issues, including hemp, ...

A new study suggests that adding cannabidiol, commonly known as CBD, to products containing caffeine and delta-9-tetrahydrocannabinol (THC) can intensify the drug’s psychoactive effects and increase ...

In a groundbreaking study, scientists at the U.S. Department of Agriculture, Agricultural Research Service (ARS) redefined the value of roots in industrial hemp, providing new opportunities for ...

President Donald Trump is expected to sign an executive order rescheduling marijuana as a Schedule III drug, placing it on the same level as Tylenol with codeine, testosterone or anabolic steroids.